- $771.42m
- $1.01bn
- $38.47m
Annual balance sheet for Apnimed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 68.3 | 41.9 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 1.11 | 0.959 |
| Prepaid Expenses | ||
| Total Current Assets | 73.2 | 45.1 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0.117 | 0.09 |
| Other Long Term Assets | ||
| Total Assets | 109 | 72.9 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 42.4 | 111 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 153 | 225 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | -43.7 | -152 |
| Total Liabilities & Shareholders' Equity | 109 | 72.9 |
| Total Common Shares Outstanding |